- Home
- RPTX
as 10-24-2025 3:56pm EST
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.
| Founded: | 2016 | Country: | Canada |
| Employees: | N/A | City: | SAINT-LAURENT |
| Market Cap: | 78.2M | IPO Year: | 2020 |
| Target Price: | $4.50 | AVG Volume (30 days): | 192.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.58 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.89 - $4.07 | Next Earning Date: | 11-07-2025 |
| Revenue: | $250,000 | Revenue Growth: | -99.64% |
| Revenue Growth (this year): | -80.35% | Revenue Growth (next year): | -2.91% |
Latest Repare Therapeutics Inc. News
RPTX Breaking Stock News: Dive into RPTX Ticker-Specific Updates for Smart Investing
GlobeNewswire
10 days ago
Prelude Therapeutics Announces Appointment of Katina Dorton, J.D., MBA to its Board of Directors
Business Wire
13 days ago
Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Business Wire
5 months ago
Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2025 Financial Results
Pharmaceutical Technology
6 months ago
Repare signs out-licensing deal with DCx Biotherapeutics
Business Wire
6 months ago
Repare Therapeutics Announces Out-Licensing of its Discovery Platforms to DCx Biotherapeutics
Business Wire
6 months ago
Repare Therapeutics Announces Six Abstracts Accepted for Presentation at AACR Annual Meeting 2025
MT Newswires
7 months ago
Repare Therapeutics Appoints Steve Forte as CEO to Succeed Lloyd Segal
Business Wire
7 months ago
Repare Therapeutics Announces Leadership Transitions
Compare RPTX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "RPTX Repare Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.